A CDC vaccine advisory committee meeting scheduled for next week has been postponed. It was the first vaccine meeting since ...
The story has been updated to correct the FDA approval date to Friday, February 14 On Friday, February 14, the FDA approved ...
Kennedy Jr.'s installation atop the nation’s health bureaucracy. The Advisory Committee on Immunization Practices (ACIP) ...
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...
The postponement comes amid concerns that HHS Secretary Robert F. Kennedy Jr., a longtime vaccine critic, could make changes ...
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results